• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session

    12/7/22 1:45:59 PM ET
    $ALVO
    $ANGH
    $ASO
    $BIVI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Telecommunications Equipment
    Consumer Discretionary
    Get the next $ALVO alert in real time by email

    Gainers

    • Prometheus Biosciences, Inc. (NASDAQ:RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
    • TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares climbed 59.1% to $0.6679 after the company reported withdrawal of registration statement.
    • BioVie Inc. (NASDAQ:BIVI) gained 26.2% to $5.87. BioVie recently announced results from two Phase 2 trials assessing NE3107's potential in Parkinson's Disease (PD) and Alzheimer's Disease (AD).
    • Bit Brother Limited (NASDAQ:BTB) climbed 23.1% to $0.4680.
    • Vor Biopharma Inc. (NASDAQ:VOR) climbed 21.4% to $5.22 after the company disclosed initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia. Vor Bio also priced underwritten offering of 15.3 million shares of common stock at $4.30 per share.
    • FLJ Group Limited (NASDAQ:FLJ) gained 19.1% to $1.59.
    • MongoDB, Inc. (NASDAQ:MDB) climbed 18.6% to $171.54 after the company reported better-than-expected sales results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
    • Titan Medical Inc. (NASDAQ:TMDI) gained 17.8% to $0.7099. Titan Medical suspended special meeting of shareholders in conjunction with initiation of strategic review process.
    • Yield10 Bioscience, Inc. (NASDAQ:YTEN) climbed 15.6% to $2.0799. Yield10 Bioscience, last month, posted a Q3 loss of $0.71 per share.
    • Replimune Group, Inc. (NASDAQ:REPL) rose 15.5% to $21.82 after the company announced it entered into a collaboration angreement with Roche, and also announced initial data from the anti-PD1 failed melanoma cohort of the IGNYTE clinical trial and an RP2/3 program update.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) gained 14.2% to $0.4799. Hillstream BioPharma recently announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
    • NEXGEL, Inc. (NASDAQ:NXGL) gained 14.1% to $1.3690. NEXGEL reported share repurchase program of up to $500,000 of the company’s common stock.
    • Wearable Devices Ltd. (NASDAQ:WLDS) jumped 13.8% to $0.74.
    • Academy Sports and Outdoors, Inc. (NYSE:ASO) rose 13.1% to $55.75 after the company reported better-than-expected Q3 EPS results and raised its FY22 EPS guidance.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) shares gained 12.4% to $0.0899 after dropping 17% on Tuesday. Very Good Food recently said it plans to launch its products at Albertsons Companies grocery stores across the U.S.
    • Qurate Retail, Inc. (NASDAQ:QRTEB) gained 10.7% to $7.50.
    • State Street Corporation (NYSE:STT) climbed 10.4% to $82.11 after the company announced a $500 million increase to existing common share repurchases in Q4.
    • Alvotech (NASDAQ:ALVO) gained 9.6% to $7.54.
    • Meta Materials Inc. (NASDAQ:MMAT) rose 9.2% to $2.13 after climbing 14% on Tuesday.
    • China Eastern Airlines Corporation Limited (NYSE:CEA) jumped 7.7% to $20.56.
    • Selina Hospitality PLC (NASDAQ:SLNA) gained 7.5% to $3.0845.


    Losers

    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares dipped 52.2% to $1.0650 after the company announced pricing of a $4.1 million public offering.
    • iBio, Inc. (NYSE:IBIO) fell 50.9% to $0.7850 after the company reported pricing of $3.5 million underwritten public offering of 3,365,385 shares at $1.04 per share.
    • Versus Systems Inc. (NASDAQ:VS) fell 46.3% to $0.80 after the company announced pricing of a $2.1 million public offering.
    • Carvana Co. (NYSE:CVNA) dropped 44.2% to $3.7422 following a downgrade from Wedbush. Reports indicate that some of the company's largest creditors have signed a pact to prevent a potential creditor fight.
    • Daktronics, Inc. (NASDAQ:DAKT) fell 34.2% to $2.1850. Daktronics decided to delay earnings call 'in order to address the determination that there is substantial doubt about the Company's ability to continue as a going concern.'
    • Winc, Inc. (NYSE:WBEV) shares fell 31.9% to $0.2382 after dropping over 15% on Tuesday.
    • SCWorx Corp. (NASDAQ:WORX) dropped 30.1% to $0.5102.
    • Grom Social Enterprises, Inc. (NASDAQ:GROM) declined 27% to $0.1125.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) declined 24% to $0.7218 after the company announced pricing of a $3 million private placement.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) dipped 22.2% to $0.2723.
    • Predictive Oncology Inc. (NASDAQ:POAI) fell 20% to $0.3949.
    • Mirati Therapeutics, Inc. (NASDAQ:MRTX) dropped 19.9% to $57.32. Mirati Therapeutics recently announced late-breaking results evaluating concurrent adagrasib and pembrolizumab in first-line advanced/metastatic non-small cell lung cancer.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) declined 19.4% to $1.90 after multiple firms downgraded the stock.
    • Anghami Inc. (NASDAQ:ANGH) dropped 18.8% to $1.98.
    • Tempo Automation Holdings, Inc. (NASDAQ:TMPO) fell 18.5% to $2.72.
    • Castor Maritime Inc. (NASDAQ:CTRM) fell 16% to $1.3099.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 15.6% to $1.0633 after dropping more than 7% on Tuesday.
    • The Lovesac Company (NASDAQ:LOVE) dropped 15.3% to $19.05 after the company reported Q3 financial results.
    • Avid Bioservices, Inc. (NASDAQ:CDMO) declined 15.3% to $12.60 after the company posted a loss for the second quarter.
    • TROOPS, Inc. (NASDAQ:TROO) fell 15.1% to $1.80.
    • Smith & Wesson Brands, Inc. (NASDAQ:SWBI) dropped 15% to $10.03 after the company reported worse-than-expected Q2 EPS and sales results.
    • Cosmos Holdings Inc. (NASDAQ:COSM) shares fell 13.6% to $0.4064 after dipping 17% on Tuesday.
    • DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) dipped 12.8% to $9.25.
    • Uniti Group Inc. (NASDAQ:UNIT) declined 12.7% to $6.15.
    • Skillsoft Corp. (NYSE:SKIL) fell 12.3% to $1.6750 following weak quarterly sales.
    • INVO Bioscience, Inc. (NASDAQ:INVO) dropped 11.7% to $0.4149. The company, last month, posted downbeat quarterly results.
    • EZCORP, Inc. (NASDAQ:EZPW) declined 11.6% to $9.34 after the company announced a private offering of $175,000,000 of convertible senior notes due 2029.
    • Zuora, Inc. (NYSE:ZUO) fell 11.5% to $6.38 after the company issued weak revenue forecast.
    • Niu Technologies (NASDAQ:NIU) fell 11.5% to $4.46 after surging around 15% on Tuesday. Niu Technologies recently reported worse-than-expected Q3 EPS results.
    • United Natural Foods, Inc. (NYSE:UNFI) dropped 11.5% to $40.33 following downbeat quarterly earnings.
    • X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) shares fell 9.6% to $1.0850 after the company reported a proposed public offering.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) fell 8.4% to $2.9850.
    • M&T Bank Corporation (NYSE:MTB) dropped 7.9% to $147.63 after Keefe, Bruyette & Woods downgraded the stock from Outperform to Market Perform and lowered its price target from $215 to $180.
    • GDS Holdings Limited (NYSE:GDS) fell 7.6% to $16.83.

    Also check this out Bitcoin Falls Below This Key Level; ImmutableX Among Top Losers.

    Get the next $ALVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALVO
    $ANGH
    $ASO
    $BIVI

    CompanyDatePrice TargetRatingAnalyst
    X4 Pharmaceuticals Inc.
    $XFOR
    3/9/2026$12.00Buy
    Guggenheim
    MongoDB Inc.
    $MDB
    3/5/2026$310.00Sector Perform → Sector Outperform
    Scotiabank
    MongoDB Inc.
    $MDB
    3/3/2026$260.00Outperform → Neutral
    Robert W. Baird
    MongoDB Inc.
    $MDB
    3/3/2026$400.00 → $340.00Outperform
    BMO Capital Markets
    MongoDB Inc.
    $MDB
    3/3/2026$475.00 → $370.00Buy
    Monness Crespi & Hardt
    MongoDB Inc.
    $MDB
    2/26/2026$455.00 → $400.00Outperform
    BMO Capital Markets
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$1.00Outperform → Neutral
    Wedbush
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$0.30Overweight → Equal Weight
    Barclays
    More analyst ratings

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Porter Brian J. bought $312,475 worth of shares (2,500 units at $124.99), increasing direct ownership by 39% to 8,898 units (SEC Form 4)

    4 - STATE STREET CORP (0000093751) (Issuer)

    3/9/26 4:00:51 PM ET
    $STT
    Major Banks
    Finance

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ALVO
    $ANGH
    $ASO
    $BIVI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-2) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 10:44:05 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-1) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-3) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Quayle J Danforth exercised 2,900 shares at a strike of $15.00 and sold $898,913 worth of shares (2,900 units at $309.97) (SEC Form 4)

    4 - CARVANA CO. (0001690820) (Issuer)

    3/9/26 5:12:01 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Director Platt Ira J. gifted 7,827 shares (SEC Form 4)

    4 - CARVANA CO. (0001690820) (Issuer)

    3/9/26 5:11:55 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEVP, Gen. Counsel & Secretary Heard Daniel L was granted 14,729 shares and covered exercise/tax liability with 6,827 shares, increasing direct ownership by 2% to 456,138 units (SEC Form 4)

    4 - Uniti Group Inc. (0002020795) (Issuer)

    3/9/26 5:07:26 PM ET
    $UNIT
    Real Estate Investment Trusts
    Real Estate

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000

    CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the purchase of $600,000 of Bitcoin as part of its ongoing digital assets treasury initiative. Following this purchase, Cosmos Health's total investment in digital assets has reached $3.1 million, reflecting the combined value of its holdings in Bitcoin and Ethereum. Greg Siokas, CEO of Cosmos Health, stated: "We continue to view select digital assets as an attractive asset class with strong upside potential. Our growing position in Bitcoin and Ethereum reflects a disciplined treasury strategy design

    3/11/26 1:45:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Academy Sports + Outdoors Increases Year-over-Year Donation to St. Jude Children's Research Hospital® to More Than $575,000

    Cumulative contributions now exceed $3.2 million since the partnership began in 2020KATY, Texas, March 11, 2026 /PRNewswire/ -- Academy Sports + Outdoors ("Academy") (NASDAQ:ASO) announced an increased year‑over‑year donation of more than $575,000 to St. Jude Children's Research Hospital®, reflecting continued growth in the organizations' annual holiday partnership. The donation was generated through sales of holiday-inspired shirts and lounge pants featuring St. Jude patient art‑inspired designs, with a portion of proceeds benefiting St. Jude. "Our partnership with St. Jude is

    3/11/26 9:05:00 AM ET
    $ASO
    Other Specialty Stores
    Consumer Discretionary

    Carvana Expands Same-Day Delivery to Los Angeles

    Local car buyers and sellers now have access to faster, more convenient service Carvana (NYSE:CVNA), an industry pioneer for buying and selling cars online, today announced the expansion of same-day vehicle delivery for customers in the greater Los Angeles area. Select local customers can now receive their vehicle as soon as the same day they place an order on Carvana.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311300577/en/Carvana Expands Same-Day Delivery to Los Angeles. With this launch, Los Angeles-area customers interested in selling their vehicles to Carvana can also take advantage of same-day pickup and drop-

    3/11/26 9:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $ALVO
    $ANGH
    $ASO
    $BIVI
    SEC Filings

    View All

    SEC Form S-8 filed by MongoDB Inc.

    S-8 - MongoDB, Inc. (0001441816) (Filer)

    3/11/26 4:10:05 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by MongoDB Inc.

    10-K - MongoDB, Inc. (0001441816) (Filer)

    3/11/26 4:06:27 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by United Natural Foods Inc.

    10-Q - UNITED NATURAL FOODS INC (0001020859) (Filer)

    3/10/26 4:33:28 PM ET
    $UNFI
    Food Distributors
    Consumer Discretionary

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on X4 Pharmaceuticals with a new price target

    Guggenheim initiated coverage of X4 Pharmaceuticals with a rating of Buy and set a new price target of $12.00

    3/9/26 9:13:19 AM ET
    $XFOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    MongoDB upgraded by Scotiabank with a new price target

    Scotiabank upgraded MongoDB from Sector Perform to Sector Outperform and set a new price target of $310.00

    3/5/26 8:23:30 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    MongoDB downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded MongoDB from Outperform to Neutral and set a new price target of $260.00

    3/3/26 8:21:24 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Leadership Updates

    Live Leadership Updates

    View All

    Academy Sports + Outdoors Grows Retail Footprint with Two New Locations in Ohio and Oklahoma

    Company plans to open a total of 20-25 new stores in fiscal 2026KATY, Texas, March 10, 2026 /PRNewswire/ -- Academy Sports + Outdoors ("Academy" or the "Company") ((ASO), a leading full-line sporting goods and outdoor recreation retailer, is excited to announce it will open two new locations in North Canton, Ohio and Muskogee, Oklahoma. With these stores, the company now has four locations in Ohio, and 14 locations in Oklahoma and is on its way to opening a total of 20-25 new stores in fiscal 2026. As Academy expands its footprint, the company is reinforcing its commitment to ma

    3/10/26 9:05:00 AM ET
    $ASO
    Other Specialty Stores
    Consumer Discretionary

    NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

    Transaction expected to approximately triple NEXGEL's annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified suite of 6 established regenerative biomaterial products, most with existing insurance reimbursement, along with three new product 510(k) filings planned for 2026, 2027, and 2028 Experienced commercial team is expected to join NEXGEL, significantly expanding the Company's sales reach and operational capabilities LANGHORNE, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of healthcare, beauty, and over-the-counter (OTC) pr

    3/10/26 8:45:00 AM ET
    $CELU
    $NXGL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Financials

    Live finance-specific insights

    View All

    Kingsoft Cloud to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 25, 2025

    BEIJING, March 9, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited (NASDAQ:KC) ("Kingsoft Cloud" or the "Company"), a leading cloud service provider in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2025 ended December 31, 2025 before the open of U.S. markets on Wednesday, March 25, 2025. Kingsoft Cloud's management will host an earnings conference call on Wednesday March 25, 2025 at 8:15 am, U.S. Eastern Time (8:15 pm, Beijing/Hong Kong Time on the same day).Preregistration InformationParticipants can register for the conference call by navigating to https://register-conf.media-server.com/register/BI62cd2e3d362448ba8a49

    3/10/26 7:00:00 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    United Natural Foods, Inc. Reports Second Quarter Fiscal 2026 Results

    United Natural Foods, Inc. (NYSE:UNFI) (the "Company" or "UNFI") today reported financial results for the second quarter of fiscal 2026 (13 weeks) ended January 31, 2026. Second Quarter Fiscal 2026 Performance (comparisons to second quarter fiscal 2025) Net sales decreased 2.6% to $7.9 billion, including a nearly 500 basis point impact from optimization actions Net income of $20 million; Net income per diluted share (EPS) of $0.31 Adjusted EBITDA(1) increased 23.4% to $179 million Adjusted EPS(1) increased to $0.62 Net cash provided by operating activities was $283 million; Free cash flow(1) was $243 million Recent Financial and Operational Summary Updating outlook to

    3/10/26 7:00:00 AM ET
    $UNFI
    Food Distributors
    Consumer Discretionary

    Academy Sports + Outdoors Increases Quarterly Cash Dividend

    KATY, Texas, March 6, 2026 /PRNewswire/ -- Academy Sports and Outdoors, Inc. (the "Company" or "Academy") (NASDAQ:ASO) announced today that on March 5, 2026, its Board of Directors declared a quarterly cash dividend of $0.15 per share of the Company's common stock with respect to the fiscal quarter ended January 31, 2026. This represents an increase of approximately 15 percent from the previous quarterly cash dividend and marks the fourth consecutive year of dividend growth. The quarterly cash dividend is payable on April 10, 2026, to stockholders of record as of the close of business on March 20, 2026.

    3/6/26 9:05:00 AM ET
    $ASO
    Other Specialty Stores
    Consumer Discretionary

    $ALVO
    $ANGH
    $ASO
    $BIVI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care